Exelixis (EXEL) Asset Utilization Ratio (2011 - 2026)
Exelixis' (EXEL) quarterly Asset Utilization Ratio came in at 0.87 in Q2 2026, up 9.92% year-on-year from 0.79 in Q2 2025, and up 6.72% quarter-over-quarter from 0.82 in Q1 2026.
Exelixis (EXEL) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Exelixis' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.87 for Q2 2026.
- On a quarterly basis, Asset Utilization Ratio rose 9.92% year-over-year to 0.87 in Q2 2026; TTM through Apr 2026 was 0.87, a 9.92% increase from a year earlier, with the FY2026 full-year figure at 0.8, up 8.79% from the prior year.
- Asset Utilization Ratio improved to 0.87 in Q2 2026 per EXEL's latest filing, from 0.82 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.87 in Q2 2026 and bottomed at 0.51 in Q2 2022.
- The 5-year median for Asset Utilization Ratio is 0.64 (2024), against an average of 0.67.
- Across the five-year window, Asset Utilization Ratio dropped 0.39% in 2022 and soared 32.42% in 2024, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.53 in 2022, then rose by 15.78% to 0.62 in 2023, then grew by 17.42% to 0.73 in 2024, then rose by 14.56% to 0.83 in 2025, then rose by 5.03% to 0.87 in 2026.
- Per Business Quant, the three latest EXEL Asset Utilization Ratio figures stand at 0.87 (Q2 2026), 0.82 (Q1 2026), and 0.83 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | 0.87 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 0.87 |
| Jan 2, 2026 | 0.82 |
| Oct 3, 2025 | 0.83 |
| Jul 4, 2025 | 0.81 |
| Apr 4, 2025 | 0.79 |
| Jan 3, 2025 | 0.73 |
| Sep 27, 2024 | 0.73 |
| Jun 28, 2024 | 0.72 |
| Mar 29, 2024 | 0.64 |
| Dec 29, 2023 | 0.62 |
| Sep 29, 2023 | 0.58 |
| Jun 30, 2023 | 0.55 |
| Mar 31, 2023 | 0.54 |
| Dec 30, 2022 | 0.53 |
| Sep 30, 2022 | 0.52 |
| Jul 1, 2022 | 0.54 |
| Apr 1, 2022 | 0.51 |
| Oct 1, 2021 | 0.52 |
| Jul 2, 2021 | 0.51 |
| Apr 2, 2021 | 0.48 |